198,167 Shares in Omega Healthcare Investors, Inc. $OHI Acquired by Biondo Investment Advisors LLC

Key Points

• Biondo Investment Advisors acquired 198,167 shares of Omega Healthcare Investors, valued at approximately $9.45 million, while institutional investors collectively own 65.25% of the REIT.
• Analysts maintain a generally neutral outlook: Omega has a consensus “Hold” rating and an average price target of $49.21, with targets ranging from $46 to $58.
• Omega reported quarterly revenue of $328.25 million and adjusted earnings of $1.19 per share, exceeding estimates. The company also raised its quarterly dividend to $0.68, representing an annualized yield of about 5.8%.

Biondo Investment Advisors LLC bought a new position in Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 198,167 shares of the real estate investment trust's stock, valued at approximately $9,449,000. Biondo Investment Advisors LLC owned approximately 0.07% of Omega Healthcare Investors as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of the business. BlackRock Inc. acquired a new position in Omega Healthcare Investors in the second quarter valued at $1,838,155,000. State Street Corp boosted its holdings in Omega Healthcare Investors by 4.8% in the second quarter. State Street Corp now owns 14,591,873 shares of the real estate investment trust's stock worth $534,792,000 after acquiring an additional 671,473 shares in the last quarter. Geode Capital Management LLC grew its position in Omega Healthcare Investors by 9.4% in the 4th quarter. Geode Capital Management LLC now owns 8,515,924 shares of the real estate investment trust's stock valued at $377,648,000 after purchasing an additional 734,774 shares during the period. Bank of New York Mellon Corp acquired a new position in shares of Omega Healthcare Investors during the second quarter valued at about $275,230,000. Finally, Invesco Ltd. boosted its stake in Omega Healthcare Investors by 8.6% during the 4th quarter. Invesco Ltd. now owns 5,368,945 shares of the real estate investment trust's stock valued at $238,059,000 after purchasing an additional 424,024 shares during the last quarter. Institutional investors own 65.25% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the stock. Scotiabank decreased their price objective on shares of Omega Healthcare Investors from $50.00 to $47.00 and set a "sector perform" rating for the company in a research note on Thursday, June 18th. BMO Capital Markets reaffirmed a "market perform" rating and set a $52.00 price objective on shares of Omega Healthcare Investors in a report on Monday, May 4th. Citigroup raised their price target on Omega Healthcare Investors from $52.00 to $58.00 and gave the stock a "buy" rating in a report on Tuesday, August 4th. Barclays began coverage on shares of Omega Healthcare Investors in a research note on Tuesday, July 7th. They set an "underweight" rating and a $51.00 price objective for the company. Finally, Truist Financial decreased their target price on Omega Healthcare Investors from $48.00 to $46.00 and set a "hold" rating on the stock in a research note on Tuesday, June 9th. Six analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, the company has an average rating of "Hold" and a consensus target price of $49.21.

Omega Healthcare Investors Stock Performance

Shares of OHI stock opened at $46.66 on Monday. The firm has a market cap of $14.14 billion, a P/E ratio of 16.66, a P/E/G ratio of 1.89 and a beta of 0.57. The business's 50 day moving average price is $48.18 and its 200-day moving average price is $47.02. Omega Healthcare Investors, Inc. has a fifty-two week low of $39.26 and a fifty-two week high of $52.39.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last posted its earnings results on Wednesday, July 29th. The real estate investment trust reported $1.19 earnings per share for the quarter, topping analysts' consensus estimates of $0.51 by $0.68. Omega Healthcare Investors had a return on equity of 15.76% and a net margin of 66.96%.The firm had revenue of $328.25 million for the quarter, compared to the consensus estimate of $266.97 million. During the same quarter in the prior year, the business earned $0.77 EPS. The business's revenue for the quarter was up 16.2% on a year-over-year basis. Omega Healthcare Investors has set its FY 2026 guidance at 3.220-3.260 EPS. As a group, equities analysts predict that Omega Healthcare Investors, Inc. will post 3.12 EPS for the current year.

Omega Healthcare Investors Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, August 14th. Shareholders of record on Monday, August 3rd were given a $0.68 dividend. This is a positive change from Omega Healthcare Investors's previous quarterly dividend of $0.67. The ex-dividend date of this dividend was Monday, August 3rd. This represents a $2.72 dividend on an annualized basis and a yield of 5.8%. Omega Healthcare Investors's payout ratio is presently 97.14%.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company's core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source